The secretome of endothelial progenitor cells: a potential therapeutic strategy for ischemic stroke

The secretome of endothelial progenitor cells: a potential therapeutic strategy for ischemic stroke

Ischemic stroke continues to be a leading cause of mortality and morbidity in the world. Despite recent advances in the field of stroke medicine, thrombolysis with recombinant tissue plasminogen activator remains as the only pharmacological therapy for stroke patients. However, due to short therapeu...

Full description

Bibliographic Details
Main Authors: Mansour Alwjwaj, Rais Reskiawan A Kadir, Ulvi Bayraktutan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Neural Regeneration Research
Subjects:
antioxidants; cell-based therapy; cell-free therapy; endothelial progenitor cells; inflammatory cytokines; regenerative medicine; secretome; stroke; vasodegeneration; vasorepair
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2021;volume=16;issue=8;spage=1483;epage=1489;aulast=Alwjwaj

Internet

http://www.nrronline.org/article.asp?issn=1673-5374;year=2021;volume=16;issue=8;spage=1483;epage=1489;aulast=Alwjwaj

Similar Items